Evidence mapPaperPMID 36079725Full record

Trial reportNutrients2022

Metabologenomic Approach Reveals Intestinal Environmental Features Associated with Barley-Induced Glucose Tolerance Improvements in Japanese: A Randomized Controlled Trial.

Yuka Goto, Yuichiro Nishimoto, Shinnosuke Murakami, Tatsuhiro Nomaguchi, Yuka Mori, Masaki Ito, Ryohei Nakaguro, Toru Kudo, Tsubasa Matsuoka, Takuji Yamada and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuka GotoHakubaku Co., Ltd., Chuo, Yamanashi 409-3843, Japan.
Yuichiro NishimotoMetagen Inc., Tsuruoka, Yamagata 997-0052, Japan.ORCID 0000-0002-4522-8717
Shinnosuke MurakamiMetagen Inc., Tsuruoka, Yamagata 997-0052, Japan.
Tatsuhiro NomaguchiMetagen Inc., Tsuruoka, Yamagata 997-0052, Japan.
Yuka MoriMetagen Inc., Tsuruoka, Yamagata 997-0052, Japan.
Masaki ItoMetagen Inc., Tsuruoka, Yamagata 997-0052, Japan.
Ryohei NakaguroMetagen Inc., Tsuruoka, Yamagata 997-0052, Japan.
Toru KudoMetagen Inc., Tsuruoka, Yamagata 997-0052, Japan.ORCID 0000-0002-7321-2659
Tsubasa MatsuokaHakubaku Co., Ltd., Chuo, Yamanashi 409-3843, Japan.ORCID 0000-0003-3580-7851
Takuji YamadaMetagen Inc., Tsuruoka, Yamagata 997-0052, Japan.
Toshiki KobayashiHakubaku Co., Ltd., Chuo, Yamanashi 409-3843, Japan.
Shinji FukudaMetagen Inc., Tsuruoka, Yamagata 997-0052, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Consumption of barley has been known to exert beneficial effects on glucose tolerance; however, it has also been reported that there are inter-individual differences in these responses. Recent evidence has suggested that these individual differences are mediated by the gut microbiota. (2) Methods: In the present study, we aimed to understand the relationship between the intestinal environment, including intestinal microbiome and their metabolome, and glucose tolerance. A randomized controlled trial with a 4-week consumption of barley or control food was conducted. We conducted an integrated analysis of the intestinal microbiome and metabolome and analyzed the relationship with improvement of glucose tolerance. (3) Results: We found that metabolites such as azelate were significantly increased after barley consumption. Furthermore, the subjects whose glucose tolerance was slightly impaired showed improvement in their glucose tolerance index following the barley consumption. Additionally, the analysis showed that the increase in the abundance of the

Indexed as

Gastrointestinal MicrobiomeHordeumGlucoseHumansIntestinesJapanGlucosebarleydietary fibergut microbiomeintestinal metabolomeprebiotics

Identifiers

PMID36079725
PMCPMC9460218

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.